# Moexipril Hydrochloride

NDC: 0093-0017
Generic name: Moexipril Hydrochloride
Labeler / Manufacturer: Teva Pharmaceuticals USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20030508

FDA application: ANDA076204

## Active ingredients

- MOEXIPRIL HYDROCHLORIDE: 7.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0093-0017"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0093-0017
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d4078f3-b621-475f-a4e6-005de2e62b32